α2-Adrenoceptor-mediated contractions of the porcine isolated ear artery: Evidence for a cyclic AMP-dependent and a cyclic AMP-independent mechanism

British Journal of Pharmacology

Volumn 124, Issue 6, 1998, Pages 1107-1114

  Roberts, R E ^a   Tomlinson, A E ^a   Kendall, D A ^a   Wilson, V G ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

2 adrenoceptors; Cyclic nucleotides; ODQ; Porcine ear artery; Sodium nitroprusside; U46619; UK14304; Vasoconstriction

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; ALPHA 2 ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ANGIOTENSIN; BRIMONIDINE; BUCLADESINE; CYCLIC AMP; CYCLIC GMP; FORSKOLIN; ISOBUTYLMETHYLXANTHINE; LEMAKALIM; NITROPRUSSIDE SODIUM; POTASSIUM CHLORIDE; PRAZOSIN; RAUWOLSCINE; UNCLASSIFIED DRUG; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; ANGIOTENSIN II; QUINOXALINE DERIVATIVE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EAR ARTERY; NONHUMAN; PRIORITY JOURNAL; SWINE; VASOCONSTRICTION; ANIMAL; ARTERY; DRUG EFFECT; EAR; IN VITRO STUDY; METABOLISM; MUSCLE CONTRACTION; MUSCLE RELAXATION; PHYSIOLOGY; VASCULARIZATION;

15-HYDROXY-11 ALPHA,9 ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID; ADRENERGIC ALPHA-AGONISTS; ANGIOTENSIN II; ANIMALS; ARTERIES; CYCLIC AMP; EAR; FORSKOLIN; MUSCLE CONTRACTION; MUSCLE RELAXATION; NITROPRUSSIDE; QUINOXALINES; RECEPTORS, ADRENERGIC, ALPHA-2; SWINE;

EID: 0031595088     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701935     Document Type: Article

References (42)

1. 2-adrenoceptor-mediated contractions of rabbit saphenous vein. Eur. J. Pharmacol., 277, 35-44.
2. AIDULIS, D.M., FUGLSANG, A., SAVAGE, S.A.H. & POLLOCK, D. (1991). Drug-induced enhancement of contractions to clonidine in rat tail artery rings in vitro. Br. J. Pharmacol., 104, 51P.
3. AIDULIS, D.M. & POLLOCK, D. (1992). Inhibition of enhanced contractions to UK-14304 by yohimbine, prazosin or a vasopressin antagonist in rat tail artery rings in vitro. Br. J. Pharmacol., 107, 183P.
4. BLAYLOCK, N.A. & WILSON, V.G. (1995). Pharmacological characterization of noradrenaline-induced contractions of the porcine isolated palmar lateral vein and palmar common digital artery. Br. J. Pharmacol., 114, 694-702.
5. BYLUND, D.B., EIKENBURG, D.C., HIEBLE, J.P., LANGER, S.Z., LEFKOWITZ, R.J., MINNEMAN, K.P., MOLINOFF, P.B. RUFFOLO, R.R. & TRENDELENBURG, U. (1994). International Union of Pharmacology nomenclature on adrenoceptors. Pharmacol. Rev., 46, 121-136.
6. 2-agonist for the characterisation of α-adrenoceptor subtypes. Eur. J. Pharmacol., 72, 413-415.
7. 1-adrenoceptors in dog saphenous vein exposed to phenoxybenzamine. Eur. J. Pharmacol., 85, 325-329.
8. 2-adrenoceptors in several isolated blood vessels from the rabbit. Br. J. Pharmacol., 99, 253-260.
9. 2-adrenoceptors. Br. J. Pharmacol., 95, 485-500.
10. DELPY, E., COSTE, H. & LE MONNIER DE GOUVILLE, A.C. (1996). Effects of cyclic GMP elevation on isoprenaline-induced increase in cyclic AMP and relaxation in rat aortic smooth muscle: role of phosphodiesterase 3. Br. J. Pharmacol., 119, 471-478.
11. 2-adrenoceptor -mediated contractions in several isolated blood vessels from the rabbit. Br. J. Pharmacol., 103, 1493-1499.
12. 2-adrenoceptors in rabbit isolated distal saphenous artery - a permissive role for angiotensin II? Br. J. Pharmacol., 96, 259-261.
13. 2+ in cultured porcine aortic smooth muscle cells. J. Cardiovasc. Pharmacol., 22, 97-103.
14. FABER, J.E. (1988). In situ analysis of α-adrenoceptors on arteriolar and venular smooth muscle in rat skeletal muscle microcirculation. Circ. Res., 62, 37-50.
15. 2+ for contraction in dog saphenous vein? Can. J. Physiol., 67, 1086-1091.
16. HEI, Y-J., MACDONNELL, K.L., MCNEILL, J.H. & DIAMOND, J. (1991). Lack of correlation between activation of cyclic AMP-dependent protein kinase and inhibition of contraction of rat vas deferens by cyclic AMP analogs. Mol. Pharmacol., 39, 233-238.
17. HIEBLE, J.P. & WOODWARD, D.F. (1984). Different characteristics of post-junctional alpha-adrenoceptors on arterial and venous smooth muscle. Naunyn-Schmiedeberg's Arch. Pharmacol., 328, 44-50.
18. 2-adrenoceptor sensitivity after in vitro isolation of arterioles. Am. J. Physiol., 265, H1988-H1995.
19. KOMAS, N., LUGNIER, C. & STOCLET, J-C. (1991). Endothelium-dependent and independent relaxation of the rat aorta by cyclic nucleotide phosphodiesterase inhibitors. Br. J. Pharmacol., 104, 495-503.
20. 2A subtype. Br. J. Pharmacol., 121, 1721-1729.
21. MCGRATH, J.C. (1982). Evidence for more than one subtype of post-junctional alpha-adrenoceptor. Biochem. Pharmacol., 31, 467-484.
22. MCGRATH, J.C., BROWN, C.M. & WILSON, V.G. (1989). α-Adrenoceptors: a critical review. Med. Res. Rev, 9, 407-535.
23. 2- adenoceptors in vitro. In Adrenoceptors, Structure, Mechanisms and Function Advances in Pharmacological Sciences, ed. Szabadi, E. & Bradshaw, P. M., Basal: Birkhauser Verlag pp. 211-220.
24. MONCADA, S., PALMER, M.J. & HIGGS, E.A. (1991). Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev., 43, 109-142.
25. 2-adrenoceptors mediate vasoconstriction in human subcutaneous resistance vessels. Br. J. Pharmacol., 97, 829-834.
26. + channels. Trends Pharmacol. Sci., 10, 431-435.
27. 1-like and angiotensin II-induced vasoconstriction and cyclic AMP content of the rabbit isolated femoral artery. Br. J. Pharmacol., 118, 627-634.
28. 2-adrenoceptor-mediated vasoconstriction in porcine isolated ear artery. Br. J. Pharmacol., 122, 126P.
29. SCHUMANN, H-J. & LUES, I. (1983). Postjunctional α-adrenoceptors in isolated saphenous vein of the rabbit. Naunyn-Schmiedeberg's Arch. Pharmacol., 323, 328-334.
30. SCHRAMMEL, A., BEHRENDS, S., SCHMIDT, K., KOESLING, D. & MAYER, B. (1996). Characterization of 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one as a heme site inhibitor of nitric oxide-sensitive guanylyl cyclase. Mol. Pharmacol., 50, 1-5.
31. SEAMON, K.B. & DALY, J.W. (1986). Forskolin: Its biological and chemical properties. Adv. Cyclic Nucleotide Res., 20, 1-150.
32. SHIMAMOTO, H., SHIMAMOTO, Y., KWAN, C-Y. & DANIEL, E.E. (1995). Activation of protein kinase C as a modulator of potentiated UK-14304-induced contractions in dog mesenteric artery and vein. J. Cardiovasc. Pharmacol., 26, 923-931.
33. 2-adrenoceptor mediating contraction of human saphenous vein. Br. J. Pharmacol., 106, 447-451.
34. SOUTHAM, E., CHARLES, S.L. & GARTHWAITE, J. (1996). The nitric oxide-cyclic GMP pathway and synaptic plasticity in the rat superior cervical ganglion. Br. J. Pharmacol., 119, 527-532.
35. 2-adrenoceptor-mediated contraction in the isolate canine saphenous artery treated with Bay K8644. Eur. J. Pharmacol., 135, 107-110.
36. TEMPLETON, A.G.B., MACMILLAN, J., MCGRATH, J.C., STOREY, N.D. & WILSON, V.G. (1989). Evidence for a population of prazosin-resistant, rauwolscine-sensitive α-adrenoceptors mediating contractions in the isolated vascular bed of the rat tail. Br. J. Pharmacol., 97, 563-571.
37. 2-adrenoceptor mediated responses. Hypertension, 25, 1424.
38. TROVATI, M., MASSUCCO, P., MATTIELLO, L., CAVALOT, F., MULARONI, E.M., HAHN, A.W. & ANFOSSI, G. (1996). Studies on the influence of insulin on cyclic adenosine monophosphate in human vascular smooth muscle cells: Dependence on cyclic guanosine monophosphate and modulation of catecholamine effects. Diabetologia, 39, 1156-1164.
39. WRIGHT, I.K., BLAYLOCK, N.A., KENDALL, D.A. & WILSON, V.G. (1995a). The relationship between density of α-adrenoceptor binding sites and contractile responses in several porcine isolated blood vessels. Br. J. Pharmacol., 114, 678-688.
40. WRIGHT, I.K., BLAYLOCK, N.A., STARK, G., KENDALL, D.A. & WILSON, V.G. (1995b). Neuropeptide Y-induced modulation of cyclic adenosine monophosphate and contractile responses in porcine isolated blood vessels. J. Physiol., 483, 111P.
41. 2-adrenoeeptor mediated contractions of the porcine isolated palmar lateral vein. Br. J. Phannacol., 114, 157-165.
42. 2-adrenoceptor-mediated stimulation of inositol 1,4,5-trisphosphate accumulation in the porcine isolated palmar lateral vein. Br. J. Pharmacol., 113, 21P.